{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-021934","form_type":"8-K","ticker":"PCSA","cik":"0001533743","company_name":"Processa Pharmaceuticals, Inc.","filed_at":"2023-06-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.295128+00:00","generated_at":"2026-06-13T19:58:06.098343+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Processa CEO presents at MedInvest Oncology Investor Conference","bullets":["Dr. David Young presented on June 21, 2023 at 12:00 PM ET in Boston.","Presentation titled 'Next Generation Chemotherapy to Improve Treatment of Cancer while Treating More Patients'.","No specific financial or pipeline data disclosed; presentation posted on Processa's investor website."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-021934","json":"https://secwatch.observer/filing/0001493152-23-021934.json","markdown":"https://secwatch.observer/filing/0001493152-23-021934.md","text":"https://secwatch.observer/filing/0001493152-23-021934.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533743/000149315223021934/0001493152-23-021934-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533743/000149315223021934/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T19:58:06.098343+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}